Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Advisory committee recommends FDA approval for TB treatment

May 6, 1998

Pharmacological profile of Otsuka's OPB-2045

May 6, 1998

Sumitomo claims beta-lactams active against resistant staphylococci

May 5, 1998

Takeda developing carbapenems for Gram-negative infections

May 5, 1998

Development update for CFC-222

May 4, 1998

Inhibitors of HRV 2A protease discovered by Lilly

May 4, 1998

BTG licenses antifungal agents to Race Pharmaceuticals

May 4, 1998

Lymphocyte-stimulating factor and methods of treating or preventing African sleeping sickness

May 1, 1998

Low-dose oral interferon alfa: a patient-friendly treatment for chronic diseases on the horizon

April 30, 1998

Oral and parenteral formulations of levofloxacin now available in U.K.

April 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026